63 results were returned
International law firm Bird & Bird advises international semiconductor design company, Arm, pro bono on a 15-month project in partnership with Be Healthy Be Mobile (a joint initiative between the World Health ...
Ewan explored the legal issues which arise at various stages of the lifecycle of a medical device; from product concept, though prototyping, testing, refinement, manufacture, marketing and placing on the market.
During 2016 and 2017 the complex litigation about part of AbbVie's patent portfolio protecting its Humira/adalimumab product drew attention in part because of the granting of a so-called Arrow declaration.
The European Court of Justice (ECJ) has ruled that a product composed of several active ingredients with a combined effect may be protected by a basic patent in force under the Supplementary Protection Certificate (SPC) ...
In the LexisNexis case analysis, Senior IP Associate, Will Smith, talks about the decision in the following matter: Neurim Pharmaceuticals (1991) Ltd & Anor v Generics UK Ltd (t\a MYLAN)  EWHC 3270 (Pat). This ...
The list of beneficiaries of transfers of value subject to compulsory disclosure in the French public “transparency” database include “persons who, in the media or on social media, present one or several health ...
In a judgment handed down today the UK Supreme Court has upheld the appeal of Kymab who had challenged Regeneron's patents covering Kymab's 'Kymouse' transgenic mouse.
International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")
The English High Court today handed down its decision in the proceedings brought by Merck KGaA, Darmstadt, Germany (the "Claimant") against Merck Sharp & Dohme Corp and others ("MSD") for breach of contract and trade ...
The Supreme Court has confirmed that a patent for a dosage regime of a drug used to treat erectile dysfunction (ED) was obvious over the prior art.